Hot Topics in Chinese Biotech
PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the interviews and found the following recurring themes at the top of…
Address: Institute of Medicinal Plant Development
151 Ma Lian Wa North Road, Haidian District
Beijing, P.R.China, 100193,China
Tel: +86 10 62899958
Web: www.abo.org.cn
ALLIANCE OF BIO-BOX OUTSOURCING, CHINA (ABO) is a member-based organization, devoted to excellence in providing high quality, efficient and cost-effective services and promoting international collaborations between China and the world.
ABO was founded in 2005 by the Beijing Pharma and Biotech Center (BPBC), together with 10 leading biotech outsourcing providers in China.
ABO provides a broad range of services, from drug discovery, pre-clinical studies, clinical trials, to registration and contract manufacturing. Alliance of Bio-Box Outsourcing China offers hassle-free outsourcing experiences with global quality standards.
Genomics Studies & Proteomics Studies, Genetic Engineering & Protein Engineering, Genetic Therapeutics, Antibody Engineering, Drug Screening Pharmacokinetics & Drug Safety Evaluation, Pilot Plan Trials, Clinical Trials, Contract Manufacturing
PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the interviews and found the following recurring themes at the top of…
As patients and consumers grow more educated and proactive in managing their own health and wellbeing, new ventures are hoping to serve their needs in not just prophylactic but also…
On 26 August 2019, the Chinese legislature, the National People’s Congress (NPC), passed the new Drug Administration Law (DAL), which came into effect on 1 December 2019 and represents one…
GemPharmatech is a fast-growing service center for production, distribution and phenotyping of gene-modified mouse models with multiple subsidiaries in China, and an upcoming one in the USA. Chairman Professor Xiang…
Cancer is one of the world’s leading causes of death and in China, the globe’s most populous country, it is an ever-increasing concern. In 2018, there were approximately 4.3 million…
According to the World Health Organization (WHO), antimicrobial resistance (AMR) is one of the biggest threats to global health, food security, and development today. If this trend is not slowed or reversed,…
Within the industry, Allergan already stands out for the interesting composition of its portfolio. For China President White Wang, this was precisely the attraction. He enthuses, “Allergan is truly a…
The pharma industry tends to see a lot of personnel movement, particularly at management levels, but since the Chinese market started heating up a few years ago, the labour market…
Mike Chen, president and CEO of ACROBiosystems, shares his global success as a manufacturer of recombinant proteins supporting biologics R&D and how he hopes to expand his business to eventually…
Rae Yuan, president of Sinovant Sciences, shares the company’s “transformer” strategy culminating in a strong pipeline of innovative products spanning eight therapeutic areas, and their mission to serve the needs…
Hans Schmid, chairman; and Enrico Magnani, GM, of global cancer supportive care leader Helsinn Pharmaceuticals’ operations in China, share the Swiss company’s strategy in China, having entered in 2012; the…
The rate of diabetes in China has exploded: the number of diabetic patients has surpassed 100 million and is expected to increase to 150 million by 2040. Dr Qinghua Wang,…
See our Cookie Privacy Policy Here
